Montero JA - Search Results

1

Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.

Silva RM, Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Gregório T, Cachulo ML, Pires IA, Cunha-Vaz JG, Murta JN. Silva RM, et al. Among authors: montero ja. Retina. 2013 Feb;33(2):309-15. doi: 10.1097/IAE.0b013e3182670fbe. Retina. 2013. PMID: 23095766

2

A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.

Arias L, Ruiz-Moreno JM, Gómez-Ulla F, Fernández M, Montero J. Arias L, et al. Retina. 2009 Nov-Dec;29(10):1444-9. doi: 10.1097/IAE.0b013e3181ae712d. Retina. 2009. PMID: 19730163

3

Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.

Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA. Ruiz-Moreno JM, et al. Among authors: montero ja. Retina. 2006 Jul-Aug;26(6):602-12. doi: 10.1097/01.iae.0000224942.59481.c9. Retina. 2006. PMID: 16829800 Clinical Trial.

4

Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.

Ruiz-Moreno JM, Montero JA, Zarbin MA. Ruiz-Moreno JM, et al. Among authors: montero ja. Retina. 2007 Apr-May;27(4):458-61. doi: 10.1097/IAE.0b013e318030c77c. Retina. 2007. PMID: 17420698

5

Photodynamic therapy for chronic central serous chorioretinopathy.

Ruiz-Moreno JM, Lugo FL, Armadá F, Silva R, Montero JA, Arevalo JF, Arias L, Gómez-Ulla F. Ruiz-Moreno JM, et al. Among authors: montero ja. Acta Ophthalmol. 2010 May;88(3):371-6. doi: 10.1111/j.1755-3768.2008.01408.x. Epub 2009 Nov 27. Acta Ophthalmol. 2010. PMID: 19958296 Free article.

6

Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.

Ruiz-Moreno JM, Montero JA, Arias L, Araiz J, Gomez-Ulla F, Silva R, Piñero DP. Ruiz-Moreno JM, et al. Among authors: montero ja. Retina. 2010 Nov-Dec;30(10):1609-15. doi: 10.1097/IAE.0b013e3181e22659. Retina. 2010. PMID: 20856171

7

Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy.

Montero JA, Ruiz-Moreno JM, Fernandez-Muñoz M. Montero JA, et al. Eur J Ophthalmol. 2011 Jul-Aug;21(4):503-5. doi: 10.5301/EJO.2011.6290. Eur J Ophthalmol. 2011. PMID: 21279982

8

Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab.

Montero JA, Ruiz-Moreno JM, Sanchis-Merino E, Perez-Martin S. Montero JA, et al. Retina. 2013 Mar;33(3):508-12. doi: 10.1097/IAE.0b013e3182695ba0. Retina. 2013. PMID: 23099497

9

INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: SIX YEARS OUTCOME.

Ruiz-Moreno JM, Montero JA, Araiz J, Arias L, García-Layana A, Carneiro A, Figueroa MS, Silva R. Ruiz-Moreno JM, et al. Among authors: montero ja. Retina. 2015 Dec;35(12):2450-6. doi: 10.1097/IAE.0000000000000632. Retina. 2015. PMID: 26049616

10

Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3.

Montero JA, Ruiz-Moreno JM, Tavolato M. Montero JA, et al. Graefes Arch Clin Exp Ophthalmol. 2003 Oct;241(10):797-802. doi: 10.1007/s00417-003-0752-3. Epub 2003 Aug 29. Graefes Arch Clin Exp Ophthalmol. 2003. PMID: 14605900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters